Tilray Brands, Inc. (NASDAQ:TLRY) Receives $13.33 Average PT from Brokerages

Tilray Brands, Inc. (NASDAQ:TLRYGet Free Report) has been given a consensus recommendation of “Hold” by the eight brokerages that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $13.3333.

A number of equities analysts have weighed in on TLRY shares. ATB Cormark Capital Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 10th. Wall Street Zen lowered Tilray Brands from a “hold” rating to a “sell” rating in a research report on Saturday, February 14th. Zacks Research upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Canaccord Genuity Group started coverage on Tilray Brands in a report on Tuesday, January 27th. They issued a “hold” rating on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, January 21st.

Check Out Our Latest Stock Analysis on Tilray Brands

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Silverlake Wealth Management LLC purchased a new stake in shares of Tilray Brands during the third quarter valued at approximately $25,000. Oppenheimer & Co. Inc. purchased a new position in Tilray Brands in the 3rd quarter worth approximately $25,000. Unified Investment Management bought a new position in Tilray Brands in the 3rd quarter valued at approximately $26,000. J.W. Cole Advisors Inc. boosted its stake in Tilray Brands by 203.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock valued at $30,000 after purchasing an additional 48,177 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Tilray Brands in the 3rd quarter worth $30,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Brands Stock Performance

Shares of Tilray Brands stock opened at $7.75 on Friday. The business has a fifty day simple moving average of $9.02 and a two-hundred day simple moving average of $11.05. The firm has a market capitalization of $902.95 million, a P/E ratio of -0.35 and a beta of 2.02. The company has a current ratio of 2.81, a quick ratio of 1.72 and a debt-to-equity ratio of 0.19. Tilray Brands has a 12 month low of $3.51 and a 12 month high of $23.20.

Tilray Brands (NASDAQ:TLRYGet Free Report) last issued its quarterly earnings results on Thursday, January 8th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.27). Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The business had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. During the same quarter in the previous year, the business earned ($0.03) earnings per share. On average, equities analysts forecast that Tilray Brands will post -0.2 earnings per share for the current fiscal year.

About Tilray Brands

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

Featured Stories

Analyst Recommendations for Tilray Brands (NASDAQ:TLRY)

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.